Cargando…
SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain
The COVID-19 pandemic and SARS-CoV-2 variants have dramatically illustrated the need for a better understanding of antigen (epitope)-antibody (paratope) interactions. To gain insight into the immunogenic characteristics of epitopic sites (ES), we systematically investigated the structures of 340 Abs...
Autores principales: | Jiang, Jiansheng, Boughter, Christopher T., Ahmad, Javeed, Natarajan, Kannan, Boyd, Lisa F., Meier-Schellersheim, Martin, Margulies, David H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275037/ https://www.ncbi.nlm.nih.gov/pubmed/37333174 http://dx.doi.org/10.21203/rs.3.rs-2800118/v1 |
Ejemplares similares
-
SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain
por: Jiang, Jiansheng, et al.
Publicado: (2023) -
Synthetic nanobody–SARS-CoV-2 receptor-binding domain structures identify distinct epitopes
por: Ahmad, Javeed, et al.
Publicado: (2021) -
Structures of synthetic nanobody–SARS-CoV-2 receptor-binding domain complexes reveal distinct sites of interaction
por: Ahmad, Javeed, et al.
Publicado: (2021) -
Structures of synthetic nanobody–SARS-CoV-2–RBD complexes reveal distinct sites of interaction and recognition of variants
por: Ahmad, Javeed, et al.
Publicado: (2021) -
Chaperone function in antigen presentation by MHC class I molecules—tapasin in the PLC and TAPBPR beyond
por: Margulies, David H., et al.
Publicado: (2023)